Literature DB >> 19172424

Invasive prenatal diagnostic practice in Denmark 1996 to 2006.

Christina H F Vestergaard1, Øjvind Lidegaard, Ann Tabor.   

Abstract

The Danish National Board of Health recommended in 2004 routine ultrasound scanning in week 12 with nuchal translucency measurement, combined with the double test to all pregnant women. Those who were found to have a risk of trisomy 21 higher than 1:300 were offered amniocentesis or chorionic villus sampling (CVS). The total number of pregnancies in Denmark with an invasive prenatal procedure decreased from 6,929 in 1996 to 3,103 in 2006, the percentage of CVS increased from 45 to 69%, and the percentage of women below 35 years among those undergoing invasive procedures increased from 38 to 52%. The mean gestational age at which the procedures were done increased--for CVS from week 11 to 13, and for amniocentesis from week 16 to 17. We thus achieved to more than double the offer of prenatal screening and at the same time reduce the number of invasive procedures by 55%.

Entities:  

Mesh:

Year:  2009        PMID: 19172424     DOI: 10.1080/00016340902730367

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Prenatal Diagnosis of Chromosome Abnormalities: A 13-Year Institution Experience.

Authors:  Carmen Comas; Mónica Echevarria; María Ángeles Rodríguez; Ignacio Rodríguez; Bernat Serra; Vincenzo Cirigliano
Journal:  Diagnostics (Basel)       Date:  2012-11-19

2.  Obstetric and non-obstetric surgery during pregnancy: A 20-year Danish population-based prevalence study.

Authors:  Anne Staub Rasmussen; Christian Fynbo Christiansen; Niels Uldbjerg; Mette Nørgaard
Journal:  BMJ Open       Date:  2019-05-19       Impact factor: 2.692

3.  Can prematurity risk in twin pregnancies after in vitro fertilization be predicted? A retrospective study.

Authors:  Andrea Weghofer; Katharina Klein; Maria Stammler-Safar; Christof Worda; David H Barad; Peter Husslein; Norbert Gleicher
Journal:  Reprod Biol Endocrinol       Date:  2009-11-25       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.